RapidHDX-MS Archives - Rapid Novor

September 2025

Rethinking Epitope-Based Patents for Stronger mAb Protection

Genya Gorshtein2026-06-16T13:20:33-04:00September 5th, 2025|Webinars|

In this webinar, you will learn:About paratope-centered patenting as a way to build stronger, structurally defined claims that withstand enablement and design-around challenges.How evolving case law, USPTO guidance, and antibody characterization tools can open new avenues for securing robust protection for therapeutic antibodies.Experimental strategies for resolving epitope and paratope including efficiently permutating and screening [...]

0

June 2024

Integrating AI and HDX-MS for Antibody Epitope Mapping

Genya Gorshtein2025-08-28T11:52:26-04:00June 5th, 2024|Webinars|

In this webinar, you will learn: How AI and HDX-MS are applied in screening, epitope mapping, and selecting neutralizing antibodies against SARS-Cov-2. The predictive capabilities of AI computational modeling and its validation and refinement by high-resolution HDX-MS. How the integration of AI with HDX-MS informs antibody characterization for the accelerated development of therapeutic [...]

0

February 2023

Nanobody Lead Optimization with Epitope Mapping and Binning

Mingjie Xie2025-08-08T16:27:14-04:00February 14th, 2023|Webinars|

In this webinar, you will learn: How Rapid Novor’s de novo polyclonal sequencing platform REpAb® can accelerate any nanobody development pipeline How SPR and HDX-MS integrate into an antibody discovery and development workflow How to choose optimal lead candidates with SPR and HDX-MS How epitopes can be characterized using SPR and HDX-MS [...]

0